What is the management approach for a 10 mm left adrenal nodule?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: July 29, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Management of 10 mm Left Adrenal Nodule

For a 10 mm left adrenal nodule, no further follow-up imaging or functional testing is required if it demonstrates benign radiologic features on initial imaging. 1

Initial Evaluation

The management of adrenal nodules depends on their size, imaging characteristics, and hormonal activity. For a 10 mm adrenal nodule:

Imaging Assessment

  1. Non-contrast CT as first-line imaging:

    • Hounsfield units (HU) measurement is crucial:
      • HU < 10: Reliably indicates benign adenoma (0% risk of adrenocortical carcinoma)
      • HU 10-20: Low risk (0.5%) of malignancy
      • HU > 20: Higher risk (6.3%) of malignancy 2
  2. If initial non-contrast CT is indeterminate (HU > 10):

    • Second-line imaging options:
      • Contrast-enhanced washout CT (>60% washout at 15 minutes suggests benign lesion)
      • Chemical-shift MRI (signal intensity loss in opposed-phase images indicates benign adenoma) 1, 2

Hormonal Evaluation

Even for small nodules, hormonal evaluation is recommended:

  1. Cortisol secretion: 1 mg overnight dexamethasone suppression test
  2. Pheochromocytoma screening:
    • Can be omitted if the nodule has unequivocal benign features (HU < 10) AND no symptoms of catecholamine excess
    • Otherwise, measure plasma or 24-hour urinary metanephrines 1, 2
  3. Primary aldosteronism screening:
    • Aldosterone-to-renin ratio if hypertension and/or hypokalemia are present 1

Management Algorithm for 10 mm Adrenal Nodule

If Benign Features (HU < 10 on non-contrast CT):

  • No further imaging or functional testing required 1, 2
  • The risk of malignancy is extremely low (0%) 2

If Indeterminate Features (HU > 10 on non-contrast CT):

  1. Perform second-line imaging (washout CT or chemical-shift MRI)
  2. Complete hormonal evaluation
  3. If second-line imaging confirms benign nature:
    • No further follow-up needed for this small 10 mm nodule 1

If Functional (hormone-producing):

  • Management depends on the specific hormone excess:
    • Cortisol-producing: Consider adrenalectomy if clinically significant Cushing's syndrome
    • Aldosterone-producing: Adrenalectomy if unilateral production confirmed
    • Pheochromocytoma: Adrenalectomy 1

Important Considerations

  • Size matters: At 10 mm, this nodule is well below the 4 cm threshold that raises concern for malignancy 1
  • Prevalence of malignancy: Only 0.3% of adrenal nodules <4 cm with unenhanced attenuation >10 HU were malignant in a multi-institutional study 3
  • Avoid unnecessary biopsy: Adrenal mass biopsy is rarely indicated and should not be routinely performed 1
  • Growth monitoring: If any concerning features are present, repeat imaging in 6-12 months may be considered, but is generally not necessary for a 10 mm nodule with benign characteristics 1, 2

Pitfalls to Avoid

  1. Over-investigation: Small (<4 cm) adrenal nodules with benign characteristics have extremely low malignancy risk and don't require extensive follow-up 1
  2. Relying solely on washout characteristics: Recent studies show washout CT has limitations - approximately 1/3 of pheochromocytomas may washout like adenomas, and 1/3 of adenomas don't show typical washout patterns 1
  3. Missing functional tumors: Even small nodules can be hormonally active, so appropriate hormonal evaluation is important 2
  4. Unnecessary surgery: For a 10 mm nodule with benign characteristics, surgery is not indicated 1

By following this evidence-based approach, the management of a 10 mm left adrenal nodule can be appropriately tailored to minimize unnecessary testing while ensuring proper evaluation of potential hormone excess.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Adrenal Adenoma Diagnosis and Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.